Cargando…
Acneiform rash as a side effect of selumetinib in a child with neurofibromatosis type 1 treated for inoperable plexiform neurofibromas: Good results with doxycycline
Autores principales: | Volontè, Martina, Isoletta, Eugenio, Gordon, Shaul, Foiadelli, Thomas, Bassanese, Francesco, Rossi, Alessandra, Marseglia, Gian Luigi, Savasta, Salvatore, Brazzelli, Valeria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541585/ https://www.ncbi.nlm.nih.gov/pubmed/35638252 http://dx.doi.org/10.1111/dth.15607 |
Ejemplares similares
-
Selumetinib in Japanese pediatric patients with neurofibromatosis type 1 and symptomatic, inoperable plexiform neurofibromas: An open-label, phase I study
por: Suenobu, Souichi, et al.
Publicado: (2023) -
Inhibition of YAP Sensitizes the Selumetinib Treatment for Neurofibromatosis Type 1 Related Plexiform Neurofibroma
por: Tian, Zhuowei, et al.
Publicado: (2023) -
Plexiform Neurofibroma in the Axilla with Intraosseous Neurofibroma in the Humerus in Neurofibromatosis 5
por: Khaladkar, Sanjay Mhalasakant, et al.
Publicado: (2018) -
Novel molecular targeted therapies for patients with neurofibromatosis type 1 with inoperable plexiform neurofibromas: a comprehensive review
por: Solares, I., et al.
Publicado: (2021) -
Congenital Craniofacial Plexiform Neurofibroma in Neurofibromatosis Type 1
por: Cacchione, Antonella, et al.
Publicado: (2021)